JPMorgan Chase & Co. Purchases 16,997 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

JPMorgan Chase & Co. boosted its position in Addus HomeCare Co. (NASDAQ:ADUS) by 10.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 183,198 shares of the company’s stock after acquiring an additional 16,997 shares during the quarter. JPMorgan Chase & Co. owned 1.01% of Addus HomeCare worth $24,371,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Rhumbline Advisers boosted its stake in shares of Addus HomeCare by 0.6% in the 2nd quarter. Rhumbline Advisers now owns 49,300 shares of the company’s stock valued at $5,724,000 after purchasing an additional 293 shares in the last quarter. TD Asset Management Inc grew its stake in shares of Addus HomeCare by 45.2% during the second quarter. TD Asset Management Inc now owns 4,500 shares of the company’s stock worth $522,000 after buying an additional 1,400 shares during the last quarter. Victory Capital Management Inc. increased its holdings in shares of Addus HomeCare by 136.5% during the second quarter. Victory Capital Management Inc. now owns 80,047 shares of the company’s stock worth $9,294,000 after buying an additional 46,199 shares in the last quarter. Arizona State Retirement System lifted its stake in shares of Addus HomeCare by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after acquiring an additional 87 shares during the last quarter. Finally, Quest Partners LLC acquired a new stake in shares of Addus HomeCare during the 2nd quarter valued at $31,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. KeyCorp began coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Oppenheimer raised their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Finally, Stephens lifted their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $133.67.

Insider Buying and Selling at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,750 shares of company stock valued at $4,930,750. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $126.42 on Thursday. The stock has a market capitalization of $2.29 billion, a P/E ratio of 28.93, a P/E/G ratio of 2.11 and a beta of 1.00. The business has a 50 day simple moving average of $125.00 and a 200 day simple moving average of $125.95. Addus HomeCare Co. has a one year low of $85.94 and a one year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same quarter last year, the firm posted $1.03 EPS. The company’s quarterly revenue was up 7.1% on a year-over-year basis. Equities analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.